Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative agerelated macular degeneration. BRAMD

被引：0
|
作者：
Schauwvlieghe, Ann-Sofie Marie Evelyn [1 ]
Dijkman, Greetje [2 ]
Hooymans, Johanna M. M. [3 ]
Verbraak, Frank D. [1 ,4 ]
Dijkgraaf, Marcel G. [5 ]
Peto, Tunde [6 ,7 ]
Vingerling, Johannes R. [8 ,9 ]
Hoyng, Carel [10 ]
Schlingemann, Reinier O. [1 ,11 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Ophthalmol, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Ophthalmol, Leiden, Netherlands
[3] Univ Med Ctr Groningen, Ophthalmol, Groningen, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Biomed Engn & Phys, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands
[6] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England
[7] UCL Inst Ophthalmol, London, England
[8] Erasmus MC, Ophthalmol, Rotterdam, Netherlands
[9] Erasmus MC, Epidemiol, Rotterdam, Netherlands
[10] Radboud Univ Nijmegen Med Ctr, Ophthalmol, Nijmegen, Netherlands
[11] Netherlands Inst Neurosci, Amsterdam, Netherlands
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
870
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study
    Schauwvlieghe, A. M. E.
    Dijkman, G.
    Hooymans, J. M.
    Verbraak, F. D.
    Hoyng, C. B.
    Dijkgraaf, M. G. W.
    Peto, T.
    Vingerling, J. R.
    Schlingemann, R. O.
    PLOS ONE, 2016, 11 (05):
  • [2] Infographic: Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration: the BRAMD study
    Yusuf, Imran H. H.
    Henein, Christin
    Sivaprasad, Sobha
    EYE, 2024, 38 (SUPPL 2) : 41 - 42
  • [3] Ranibizumab versus Bevacizumab in the Netherlands: Comparing the Efficacy of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration - The BRAMD Study
    Schauwvlieghe, A. M. E.
    Dijkman, G.
    Hooymans, J. M.
    Verbraak, F. D.
    Hoyng, C. B.
    Dijkgraaf, M. G. W.
    Peto, T.
    Zwinderman, A. H.
    Vingerling, J. R.
    Schlingemann, R. O.
    OPHTHALMOLOGICA, 2013, 230 : 2 - 3
  • [4] Bevacizumab and ranibizumab in exudative age-related macular degeneration: Is the effectiveness conditioned by accessibility?
    Luna Pinto, Jose
    Real, Juan
    Urrets-Zavalia, Julio
    Juarez, Claudio
    Palma, Santiago
    Granero, Gladys
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] Bevacizumab versus ranibizumab for neovascular agerelated macular degeneration: a Meta-analysis
    Wen-Jie Wang
    Jian Chen
    Xiao-Ling Zhang
    Min Yao
    Xiao-Yong Liu
    Qing Zhou
    Yi-Xin Qu
    International Journal of Ophthalmology, 2015, (01) : 138 - 147
  • [6] Laser treatment in 341 patients with exudative agerelated macular degeneration
    Leyla Atmaca
    Aysun Idil
    Pelin Atmaca-Snmez
    International Journal of Ophthalmology, 2011, (01) : 73 - 77
  • [7] Comparison of bevacizumab and ranibizumab in agerelated macular degeneration: a systematic review and meta-analysis
    Xiao-Yu Zhang
    Xiao-Fan Guo
    Shao-Dan Zhang
    Jing-Na He
    Cao-Yu Sun
    Yin Zou
    Han-Si Bi
    Yang Qu
    International Journal of Ophthalmology, 2014, 7 (02) : 355 - 364
  • [8] OUTCOMES AFTER CATARACT SURGERY IN PATIENTS WITH NEOVASCULAR AGERELATED MACULAR DEGENERATION.
    Gillies, Mark
    Daien, Vincent
    Nguyen, Vuong
    Morlet, Nigel
    Arnold, Jennifer
    Essex, Rohan
    Young, Stephanie
    Hunyor, Alex
    Barthelmes, Daniel
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 36 - 36
  • [9] Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
    Karagiannis, Dimitrios A.
    Ladas, Ioannis D.
    Parikakis, Efstratios
    Georgalas, Ilias
    Kotsolis, Athanasios
    Amariotakis, Giorgos
    Soumplis, Vasileios
    Mitropoulos, Panagiotis
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 457 - 461
  • [10] Antiplatelet and anticoagulant drugs do not affect visual acuity in the comparing bevacizumab to ranibizumab in age-related macular degeneration (BRAMD) trial
    Schauwvlieghe, A. M. E.
    Buitendijk, G. H. S.
    Dijkman, G.
    Hoyng, C.
    Hooymans, J. M.
    Verbraak, F. D.
    Vingerling, J. R.
    Claver, C. C.
    Schlingemann, R. O.
    ACTA OPHTHALMOLOGICA, 2017, 95 : 22 - 23
12345